User profiles for D. Moher

David Moher

Ottawa Hospital Research Institute
Verified email at ohri.ca
Cited by 687487

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement

D Moher, DJ Cook, S Eastwood, I Olkin, D Rennie… - The Lancet, 1999 - thelancet.com
Background The Quality of Reporting of Meta-analyses (QUOROM) conference was convened
to address standards for improving the quality of reporting of meta-analyses of clinical …

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

D Moher, KF Schulz, DG Altman - The lancet, 2001 - thelancet.com
To comprehend the results of a randomised controlled trial (RCT), readers must understand
its design, conduct, analysis, and interpretation. That goal can be achieved only through …

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

D Moher, L Shamseer, M Clarke, D Ghersi, A Liberati… - Systematic reviews, 2015 - Springer
Systematic reviews should build on a protocol that describes the rationale, hypothesis, and
planned methods of the review; few reviews report whether a protocol exists. Detailed, well-…

[HTML][HTML] Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

D Moher, A Liberati, J Tetzlaff, DG Altman… - International journal of …, 2010 - Elsevier
Systematic reviews and meta-analyses have become increasingly important in health care.
Clinicians read them to keep up to date with their field, 1, 2 and they are often used as a …

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

D Moher, A Jones, DJ Cook, AR Jadad, M Moher… - The Lancet, 1998 - thelancet.com
Background Few meta-analyses of randomised trials assess the quality of the studies
included. Yet there is increasing evidence that trial quality can affect estimates of intervention …

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials

D Moher, S Hopewell, KF Schulz, V Montori… - Bmj, 2010 - bmj.com
Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs)
is not optimal. Without transparent reporting, readers cannot judge the reliability and …

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

…, J Thomas, AC Tricco, VA Welch, P Whiting, D Moher - Bmj, 2021 - bmj.com
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement,
published in 2009, was designed to help systematic reviewers transparently report why …

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

…, PJ Devereaux, J Kleijnen, D Moher - Annals of internal …, 2009 - acpjournals.org
… IU/d) and higher-dose vitamin D (700-800 IU/d), separately. A vitamin D dose of 700 to 800
IU/d … No significant benefit was observed for RCTs with 400 IU/d vitamin D (2 RCTs with 3722 …

Epidemiology and reporting characteristics of systematic reviews

D Moher, J Tetzlaff, AC Tricco, M Sampson… - PLoS …, 2007 - journals.plos.org
Background Systematic reviews (SRs) have become increasingly popular to a wide range
of stakeholders. We set out to capture a representative cross-sectional sample of published …

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

L Shamseer, D Moher, M Clarke, D Ghersi, A Liberati… - Bmj, 2015 - bmj.com
… Where more than one criterion is provided, we will use the HAM-D for judging the response
and then follow the sequence described above. Despite the problems surrounding scale-…